Odomzo (sonidegib capsules – Novartis) — Cigna
Basal Cell Carcinoma, Metastatic
Initial criteria
- Patient is age ≥ 18 years
- Disease is limited to nodal metastases (includes primary or recurrent nodal metastases)
- Patient with distant metastases does not meet this requirement
Approval duration
1 year